iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://statista.com/statistics/1097393/revenue-for-intellia-therapeutics/
Revenue of Intellia Therapeutics U.S. 2015-2023 | Statista

Revenue of Intellia Therapeutics 2015-2023

Published by
Matej Mikulic,
Mar 15, 2024
The collaboration revenue of Intellia therapeutics in 2023 was 36.3 million U.S. dollars. Intellia Therapeutics is a U.S.-based biotech company focusing on the development of therapeutics using CRISPR technology.

Revenue of Intellia Therapeutics from 2015 to 2023 (in million U.S. dollars)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

United States

Survey time period

2015 to 2023

Supplementary notes

The statistic describes the company's collaboration revenue.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Cancer in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Cancer in the U.S.

Overview

5

Incidence rates

6

Death rates

8

Probability of surviving

5

Risk factors

8

Miscellaneous

3

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

CRISPR genome editingGlobal pharmaceutical industryBiotech drugsGenetically modified cropsAgriculture in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.